Owkin believes that medical research should be collaborative, inclusive, and privacy-preserving. Today, Owkin is pioneering AI in healthcare. It leverages its collaborative federated learning software and expert AI capabilities to bring solutions to optimize drug development and improve patient care in oncology. Owkin’s work has been published in Nature Medicine and other top-tier journals. Owkin has raised over $70M from leading VC funds and is now working with the most prominent cancer centers and pharmaceutical companies in Europe and the US. Additionally, Owkin leads several federated learning consortia, including; MELLODDY, to facilitate 'co-opetive' drug discovery between pharma companies, and Healthchain, to allow collaborative research across multiple hospitals. Owkin was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology, and by Gilles Wainrib, Ph.D., an academic pioneer in the field of Artificial Intelligence in biology.

Biotechnology

Owkin

The Paris office focuses on advanced diagnostics, data science, and AI technology development in healthcare.

Paris

The London office focuses on innovative biological research, regulatory compliance, and strategic partnerships in the UK.

London

Owkin's headquarters in New York, NY, United States

This department focuses on developing and optimizing machine learning models and algorithms to enhance data-driven decision making.

Machine Learning

This department focuses on scientific research and development to advance knowledge and innovation.

Research Department

This department analyzes data to derive insights and support decision-making across the organization.

Data Science

This department oversees the development and strategy of products, ensuring alignment with market needs and organizational goals.

Product Management

The Scientific Advisory Team at Owkin plays a critical role in guiding the company's research and development strategies. Comprised of expert scientific advisors, the team provides insights and recommendations on leveraging AI for drug development and patient care in oncology. They ensure scientific rigor and relevance in Owkin's projects, collaborating with prominent cancer centers and pharmaceutical companies to optimize outcomes and advance medical research.

Scientific Advisory Team

This department focuses on establishing and nurturing partnerships to drive business growth and collaboration.

People (9)

Jobs (0)

Other teams

Research Department

Data Science

Product Management

Scientific Advisory Team

Partnership Management